These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19496245)

  • 21. [Prophylactic and therapeutic vaccines against human papilloma virus].
    Albers AE; Hoffmann TK; Klussmann JP; Kaufmann AM
    HNO; 2010 Aug; 58(8):778-90. PubMed ID: 20544168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia.
    Shefer A; Markowitz L; Deeks S; Tam T; Irwin K; Garland SM; Schuchat A
    Vaccine; 2008 Aug; 26 Suppl 10():K68-75. PubMed ID: 18847559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The occurrence of human papillomavirus--HPV in the biopsies from colon polyps and cancer].
    Młynarczyk B; Malejczyk M; Muszyński J; Majewski S
    Med Dosw Mikrobiol; 2009; 61(2):191-6. PubMed ID: 19780498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.
    Kahn JA; Cooper HP; Vadaparampil ST; Pence BC; Weinberg AD; LoCoco SJ; Rosenthal SL
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2325-32. PubMed ID: 19661092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tracheal papillomatosis: what do we know so far?
    Harris K; Chalhoub M
    Chron Respir Dis; 2011; 8(4):233-5. PubMed ID: 21971565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV vaccination and recurrent respiratory papillomatosis.
    Jeyakumar A; Mitchell R
    Otolaryngol Head Neck Surg; 2011 Jan; 144(1):133. PubMed ID: 21493406
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 29. Human papillomavirus vaccination.
    Nicholson AJ
    Ir Med J; 2008; 101(10):318. PubMed ID: 19205147
    [No Abstract]   [Full Text] [Related]  

  • 30. [To screen or to prevent cervical carcinoma?].
    Haguenoer K; Rusch E; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37(1):1-2. PubMed ID: 18068908
    [No Abstract]   [Full Text] [Related]  

  • 31. Human papillomavirus infection and the HPV vaccine: what are the facts?
    Conner MR; Collins MM
    JAAPA; 2008 Oct; 21(10):32-4, 37. PubMed ID: 19024635
    [No Abstract]   [Full Text] [Related]  

  • 32. Questions over human papillomavirus vaccine in the US and Australia.
    Tanne JH
    BMJ; 2007 Jun; 334(7605):1182-3. PubMed ID: 17556447
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus infections and vulvar disease development.
    Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
    Callréus T; Svanström H; Nielsen NM; Poulsen S; Valentiner-Branth P; Hviid A
    Vaccine; 2009 May; 27(22):2954-8. PubMed ID: 19428906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.
    Ojaimi S; Buttery JP; Korman TM
    Vaccine; 2009 Aug; 27(36):4876-8. PubMed ID: 19555713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brachial plexus neuritis following HPV vaccination.
    Debeer P; De Munter P; Bruyninckx F; Devlieger R
    Vaccine; 2008 Aug; 26(35):4417-9. PubMed ID: 18602437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
    Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
    J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report.
    Yonee C; Toyoshima M; Maegaki Y; Kodama Y; Hayami H; Takahashi Y; Kusunoki S; Uchibori A; Chiba A; Kawano Y
    Neuropediatrics; 2013 Oct; 44(5):265-7. PubMed ID: 23378179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hear all about it: nightly television news coverage of cervical cancer vaccination in the United States.
    Wallace LS; Ache KA
    J Low Genit Tract Dis; 2009 Jul; 13(3):154-8. PubMed ID: 19550212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System.
    Borja-Hart NL; Benavides S; Christensen C
    Ann Pharmacother; 2009 Feb; 43(2):356-9. PubMed ID: 19155346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.